Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 12,581 | 3,206 | 3,340 | 2,329 | 2,113 |
| Gross Profit | 12,581 | 3,206 | 3,340 | 2,329 | 2,113 |
| Operating Expenses | 23,555 | 24,002 | 21,748 | 20,971 | 17,789 |
| Operating Income | -10,974 | -20,796 | -18,408 | -18,642 | -15,676 |
| Interest Expense | 506 | 560 | 762 | 763 | 772 |
| Other Income | 159 | 35 | 12 | 18 | 67 |
| Pre-tax Income | -11,321 | -21,321 | -19,158 | -19,387 | -16,381 |
| Income Tax | 4,444 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -15,765 | -21,321 | -19,158 | -19,387 | -16,381 |
| Net Income | $-15,765 | $-21,321 | $-19,158 | $-19,387 | $-16,381 |
| EPS Basic Total Ops | -0.11 | -0.15 | -0.24 | -0.23 | -0.21 |
| EPS Basic Continuous Ops | -0.11 | -0.15 | -0.19 | -0.20 | -0.18 |
| EPS Diluted Total Ops | -0.11 | -0.15 | -0.24 | -0.23 | -0.21 |
| EPS Diluted Continuous Ops | -0.11 | -0.15 | -0.19 | -0.20 | -0.18 |
| EBITDA(a) | $-10,580 | $-20,369 | $-17,961 | $-18,206 | $-15,233 |